A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
Recruiting · NCT07227025 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-09-25 | NCT07227025 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Janssen Research & Development, LLC | 188 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ankara Bilkent Sehir Hastanesi | Çankaya | Turkey (Türkiye) | 2 |
| Ankara Universitesi Hastaneleri Tibbi Farmakoloji Anabilim Dali Faz 1 Klinik Arastirma Merkezi | Ankara | Turkey (Türkiye) | 3 |
| Asan Medical Center | Seoul | South Korea | 338 |
| Harbin medical university cancer hospital | Harbin | China | 6 |
| Koc Universitesi Hastanesi Faz 1 Klinik Arastirma Merkezi | Istanbul | Turkey (Türkiye) | 3 |
| New York University Langone Medical Center | New York | United States | 23 |
| Princess Margaret Hospital | Toronto | Canada | 21 |
| Samsung Medical Center | Seoul | South Korea | 375 |
| Severance Hospital Yonsei University Health System | Seoul | South Korea | 90 |
| Shanghai East Hospital | Shanghai | China | 2 |
| The First Affiliated Hospital Sun Yat sen University | Guangzhou | China | 4 |
| Virginia Cancer Specialists | Fairfax | United States | 109 |